Verapamil inhibits elastase release and superoxide anion production in human neutrophils

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 2, 1998, Pages 109-112

  Khalfi, Farid ^a   Gressier, Bernard ^a   Dine, Thierry ^a   Brunet, Claude ^a   Luyckx, Michel ^a   Ballester, Louis ^a   Cazin, Micheline ^a   Cazin, Jean Claude ^a  

^a UNIV LILLE   (France)

Author keywords

Cytosolic calcium; Elastase; PMN; Superoxide anion; Verapamil

Indexed keywords

CALCIMYCIN; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; ELASTASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE; VERAPAMIL;

ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM MOBILIZATION; CHANNEL GATING; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NEUTROPHIL;

EID: 0031912295     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.109     Document Type: Article

References (29)

1. Halliwell B., Amer. J. Med., 91(3C), 14S-22S (1991).
2. Weiss S. J., N. Engl. J. Med., 320, 365-376 (1989).
3. Iwamura H., Moore A. R., Willoughby D. A., Biochim. Biophys. Acta., 1156, 295-301 (1993).
4. Mitchinson M. J., Ball R. Y., Lancet., 18, 146-149 (1987).
5. Fulop T., Jr., Jacob M. P., Varga Z. S. Foris G., Leovey A., and Robert L., Biol. Biophys. Res. Comm., 141, 92-98 (1986).
6. Wallaert B., Gressier B., Aerts C., Mizon C., Voisin C. and Mizon J., Am. J. Respir. Cell. Mol. Biol., 5, 437-444 (1991).
7. Lehr H. A., Seemuller J., Hubner C., Menger M.G., and Messmer K., Arterioscler. Thromb., 13, 1013-1018 (1993).
8. Sakamoto S., Fujie K., Handa H., Arzneim. Forsch. Drug. Res., 41, 781-785 (1991).
9. Nishizuka Y., Science, 233, 305-315 (1986).
10. von Tscharner V., Prod'hom B., Baggiolini M., and Reuter H., Nature (London), 324, 369-372 (1986).
11. Kessels R. G. C., Ross D., Verhoeven A. J., J. Biol. Chem., 266, 23152-23156 (1991).
12. Maridonneau-Parini I., Tringale M., Tauber A. I., J. Immunol., 137, 2925-2929 (1986).
13. Kawada M., Edashige K., Watanabe Y., Yasuda T., and Utsumi K., Physiol. Chem. Phys., 25, 237-252 (1993).
14. Weisdorf D. J., Thayer M. S., J. Lab. Clin. Med. 114, 260-265 (1989).
15. Werner U., Seitz O., Szelenyi I., Agent Action, 38, C112-C114 (1993).
16. Turner N. C., Wood L. J., Szelenyi I., Eur. Respir. J., 7, 934-940 (1994).
17. Karnad A. B., Hartshorn K. L., Tauber A. I., Agent Action, 31, 79-85 (1990).
18. Irita K., Fujita I., Takeshige K., Minakami S., and Yoshitake J., Biochem. Pharmacol., 35, 3455-3471 (1986).
19. Kokot K., Teschner M., Schaefer R. M., and Heidland A., Mineral Electrolyte Metab., 13, 133-140 (1987).
20. Cabanis A., Gressier B., Lebegue S., Brunet C., Dine T., Luyckx M., Cazin M. and Cazin J. C., APMIS, 102, 119-121 (1994).
21. Gressier B., Lebegue S., Brunet C., Dine T., Luyckx M., Cazin M. and Cazin J. C., Int. J. Pharm., 104, 151-156 (1994).
22. Cohen H. J., Chovaniec R. E., J. Clin. Invest., 61, 1081-1087 (1978).
23. Aruoma O. I., Halliwell B., Hoey B. M., and Butler J., Free Radical Biol. Med., 6, 593-597 (1989).
24. Gressier B., Cabanis A., Lebegue S., Brunet C., Dine T., Luyckx M., Cazin M. and Cazin J.C., Pharm. World Sci., 17, 76-80 (1995).
25. Flaherty J. T., Amer. J. Med., 91(3C), 79S-85S (1991).
26. Wallaert B., Gressier B., Marquette C. H., Gosset P., Remy-Jardin M., Mizon J. and Tonnel AB., Am. Rev. Respir. Dis., 147, 1537-1543 (1993).
27. Wong K., Kwan-Yeung L., Toxicol. Appl. Pharmacol., 107, 514-525 (1991).
28. Rosales C., Brown E. J., J. Biol. Chem., 267, 1443-1448 (1992).
29. Nilsson J., Sjolund M., Palmberg L., Von Eulee A. M., Jonzon B., and Thyberg J., Atherosclerosis, 58, 109-122 (1985).